pharmaphorum24d
Mylan finalises $465m deal with US government over EpiPen
Mylan has finalised an agreement to pay the US government $465 million, resolving a case accusing the pharma company of overcharging for its EpiPen anti-allergy pen. EpiPens provide a potentially ...
pharmaphorum1mon
What doctors say about EpiPen pricing
The furore over Mylan’s ‘price gouging’ in relation to EpiPen in the US went global, thanks to social media. Daniel Ghinn examines the reaction of healthcare professionals on social media ...
WPTV-TV11d
What you need to know about the EpiPen shortage
However, as of May 2018, Mylan’s brand-name EpiPen, as well as its authorized generic, Adrenaclick, were all added to the Food and Drug Administration’s drug shortage list. That means those ...
Business Insider India1y
Here what the EpiPen maker says about why it won't just cut the drug's price
Why doesn't it just cut the price? The EpiPen, a device used in emergencies to treat severe allergic reactions, costs 500% more than it did when Mylan acquired it in 2007. To fend off public ...
Business Insider India1y
An EpiPen is 500% more expensive than it was in 2007 - here's how that happened
The EpiPen is a device used in emergencies to treat anaphylaxis, a severe allergic reaction that can make people go into shock, struggle to breathe, or get a skin rash. Since 2007, when Mylan ...
BBC11mon
EpiPen users told they can use some devices past normal expiry date
In response to the shortages, the Medicines and Healthcare Products Regulatory Agency (MHRA) said it had agreed to a request by Mylan, the company behind EpiPen, to extend the expiry date of some ...